Showing results (111-120 of 274) with videos related to
Sort By:
Pageof 28
Regulatory Peptides|October 20, 1993
Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS)R Eshet, B Klinger, A Silbergeld, et al.Hormone Research|January 1, 1987
Greater efficiency of human growth hormone therapy in children below five years of age with growth hormone deficiency. A 5-year follow-up studyZ Josefsberg, B Bauman, A Pertzelan, et al.Health & Social Work|May 1, 1990
Cognitive and behavioral determinants of compliance in diabeticsS Amir, C Rabin, A GalatzerLancet (London, England)|May 23, 1992
Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfismZ Laron, S Anin, Y Klipper-Aurbach, et al.Clinical Endocrinology|August 1, 1991
Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfismZ Laron, B Klinger, L T Jensen, et al.European Journal of Endocrinology|July 1, 1995
Growth hormone (GH)-releasing heptapeptide, but not GH-releasing hormone, inhibits thyrotropin-stimulated thyroid hormone secretion and cAMP formation in cultured human thyroid folliclesZ Kraiem, C Y Bowers, E Sobel, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|May 23, 2000
Month of birth and subsequent development of type I diabetes (IDDM)Z Laron, I Shamis, D Nitzan-Kaluski, et al.Clinical Endocrinology|May 1, 1975
The LH response to LH releasing hormone in children with true isosexual precocious puberty treated with cyproterone acetateR Kauli, R Prager-Lewin, R Keret, et al.Clinical Endocrinology|February 1, 1982
Adrenocortical function in children with precocious sexual development during treatment with cyproterone acetateM S Stivel, R Kauli, H Kaufman, et al.Acta Paediatrica Scandinavica|July 1, 1978
Gonadal dysfunction in patients with ataxia telangiectasiaZ Zadik, S Levin, R Prager-Lewin, et al.Pageof 28